Document is current

Article History

Received: 9 June 2021

Accepted: 15 December 2021

First Online: 9 May 2022

Declarations

:

: Ethics approval was not required for this study as per the temporary arrangement from the Confidentiality Advisory Group (CAG) made for COVID-19 studies going through the fast-track review process which allowed patient information to be processed without consent for research and non-research activities.Reference: NHS health research authority. Guidance for using patient data [Internet]. Health Research Authority. 2021 [cited 2021 Jun 9]. Available from:

: Not Applicable.

: Dr. Avgi Loizidou BSc (Hon) MBChB: no competing interests.Mr. Taranjit Singh Tatla, PhD, FRCS (ORL-HNS): NIHR Local Collaborative Research Network Clinical Research Lead for ENT, 2013-2020 NIHR national specialty group champion for ENT Industry Research (tasked to engage and support commercial parties in Pharma and MedTech). Member of Ambu UK ENT KOL Advisory Board and Honorary Secretary ENT-UK.Ian Harvey PhD: no competing interests.Miriayi Aibibula PhD: Clinical Marketing Team Lead, Ambu Limited, UK.Dr. Justin Roe PhD, FRCSLT: no competing interests.Mr. Neeraj Sethi, PhD, FRCS (ORL-HNS): NIHR Local Collaborative Research Network Clinical Research Lead for ENT, Member of Ambu UK ENT KOL Advisory Board.Professor Anne GM Schilder MD, PhD: Director of the National Institute for Health Research University College London Biomedical Research Centre Hearing Theme and National Specialty Lead of the National Institute for Health Research Clinical Research Network ENT, I advise companies in the hearing domain on their clinical development programmes. Member of the Ambu UK ENT KOL Advisory Board.